Ilan Daskal - 21 Jul 2022 Form 4 Insider Report for NATUS MEDICAL INC

Role
Director
Signature
/s/ DOUGLAS BALOG by POWER OF ATTORNEY
Issuer symbol
N/A
Transactions as of
21 Jul 2022
Net transactions value
-$634,390
Form type
4
Filing time
21 Jul 2022, 17:14:17 UTC
Previous filing
17 Jun 2022
Next filing
06 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTUS Common Stock, $0.001 par value per share Disposed to Issuer $634,390 -18,937 -100% $33.50 0 21 Jul 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Ilan Daskal is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Disposed of pursuant to the previously announced Agreement and Plan of Merger, dated April 17, 2022, between Prince Parent Inc, Prince Mergerco Inc. and Issuer ("Merger Agreement").
F2 Each share of Common Stock was cancelled pursuant to the Merger Agreement in exchange for the right to receive the cash consideration provided in the Merger Agreement, subject to the applicable tax withholding.